Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

Stock Recap
#PipelineProspector

Hydrocodone Bitartrate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

30 API Suppliers, 17 USDMF, 1 KDMF, 14 NDC API, 9 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

41 Drugs in Development

41 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

349 FDF Dossiers, 337 FDA Orange Book, 3 Canada, 9 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, EXTENDED RELEASE;ORAL - 10MG, CAPSULE, EXTENDED RELEASE;ORAL - 15MG, CAPSULE, EXTENDED RELEASE;ORAL - 20MG, CAPSULE, EXTENDED RELEASE;ORAL - 30MG, CAPSULE, EXTENDED RELEASE;ORAL - 40MG, CAPSULE, EXTENDED RELEASE;ORAL - 50MG, SOLUTION;ORAL - 4MG/5ML;5MG/5ML, SOLUTION;ORAL - 200MG/5ML;2.5MG/5ML, SOLUTION;ORAL - 200MG/5ML;2.5MG/5ML;30MG/5ML, SOLUTION;ORAL - 4MG/5ML;5MG/5ML;60MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;ORAL - 5MG/5ML;60MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 1.5MG;5MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Evonik, 5 Rochem International Inc, 6 SPI Pharma, 13 DKSH, 2 Pharm-RX Chemical, 10 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 7 Kirsch Pharma, 4 ACG Worldwide, 14 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 35 BASF, 1 Bioplus Life Sciences, 3 CD Formulation, 1 Clariant, 16 Corel Pharma Chem, 7 DFE Pharma, 1 Esteem Industries, 2 Finar, 13 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 5 Ideal Cures, 4 Ingredion Pharma Solutions, 26 Kerry, 3 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 5 Novo Excipients, 4 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 35 Roquette, 14 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 3 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus, 3 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

79 Fillers, Diluents & Binders, 58 Coating Systems & Additives, 46 Thickeners and Stabilizers, 43 Direct Compression, 40 Disintegrants & Superdisintegrants, 39 Granulation, 38 Controlled & Modified Release, 30 Solubilizers, 29 Taste Masking, 29 Film Formers & Plasticizers, 26 Parenteral, 23 Topical, 20 Lubricants & Glidants, 14 Chewable & Orodispersible Aids, 14 Co-Processed Excipients, 10 Emulsifying Agents, 10 Rheology Modifiers, 9 Empty Capsules, 8 API Stability Enhancers, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

97 News #PharmaBuzz

97 News #PharmaBuzz

GLOBAL SALES INFORMATION

30 US Medicaid Prescriptions, 6 Annual Reports

MARKET PLACE

4 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

254 US Patents

254 US Patents

REF. STANDARDS & IMPURITIES

7 Others

7 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
31/10/2025	Mallinckrodt Pharmaceuticals	Ireland	Nosa Chemical Co., Ltd.	20220525-211-J-1305	hydrocodone tartrate	2022-05-25	SpecGx LLC	U.S.A	3600 North 2nd Street, St. Louis, MO 63147, USA

Hydrocodone Bitartrate

Hydrocodone Bitartrate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

30 API Suppliers

17 USDMF

1 KDMF

14 NDC API

9 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

41 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

349 FDF Dossiers

337 FDA Orange Book

3 Canada

9 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, EXTENDED RELEASE;ORAL - 10MG

CAPSULE, EXTENDED RELEASE;ORAL - 15MG

CAPSULE, EXTENDED RELEASE;ORAL - 20MG

CAPSULE, EXTENDED RELEASE;ORAL - 30MG

CAPSULE, EXTENDED RELEASE;ORAL - 40MG

CAPSULE, EXTENDED RELEASE;ORAL - 50MG

SOLUTION;ORAL - 4MG/5ML;5MG/5ML

SOLUTION;ORAL - 200MG/5ML;2.5MG/5ML

SOLUTION;ORAL - 200MG/5ML;2.5MG/5ML;30MG/5ML

SOLUTION;ORAL - 4MG/5ML;5MG/5ML;60MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;ORAL - 5MG/5ML;60MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 1.5MG;5MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Evonik

5 Rochem International Inc

6 SPI Pharma

13 DKSH

2 Pharm-RX Chemical

10 Boai NKY Pharmaceuticals Ltd

7 Gangwal Healthcare

7 Nanjing Well Pharmaceutical

1 Pfanstiehl

7 Kirsch Pharma

4 ACG Worldwide

14 Actylis

1 Aeon Procare

2 Alcedo Pharmachem

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

35 BASF

1 Bioplus Life Sciences

3 CD Formulation

1 Clariant

16 Corel Pharma Chem

7 DFE Pharma

1 Esteem Industries

2 Finar

13 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

5 Ideal Cures

4 Ingredion Pharma Solutions

26 Kerry

3 Keval Exports

4 Kima Chemical

6 Lonza Capsugel

16 Microlex e.U

1 Nanjing Bold Chemical

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

5 Novo Excipients

4 Pharmatrans-Sanaq

8 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

35 Roquette

SOLUTION;ORAL - 4MG/5ML;5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;ORAL - 5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons